Long-term performance of 555 aortic homografts in the aortic position.
Long-term results with 555 aortic homografts used for isolated aortic valve replacement (AVR) between 1964 and 1986 were analyzed to assess valve performance and the time-related onset of valve-related events. The total follow-up was 2,931 patient-years. Twenty years after operation, overall survival was 51.6 +/- 8.1%, freedom from valve-related death was 67.1 +/- 8.9%, freedom from primary tissue failure was 12.4 +/- 4.8%, freedom from infective endocarditis was 82.7 +/- 4.3%, freedom from surgical technical failure was 88.1 +/- 2.3%, and freedom from all complications including valve-related death was 9.0 +/- 3.5%. The incidence of thromboembolism was 0.034% per patient-year (one potential event). Long-term results after homograft insertion for aortic stenosis were significantly better than those after insertion for aortic incompetence. It is concluded that the good quality of life and the median life expectancy, which extends more than 20 years after operation, make the homograft an excellent choice for AVR.